JENNIFER CAMPBELL: Open Payments
NPI 1922515972 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,001 in 31 payments from 8 companies in 2025. Trend: 2023 $3,161 · 2024 $3,067 · 2025 $1,001
Food & beverage: $1,001
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 11 | $299 |
| EMD Serono, Inc. | 8 | $257 |
| TG Therapeutics, Inc. | 2 | $200 |
| Novartis Pharmaceuticals Corporation | 3 | $99 |
| ABBVIE INC. | 3 | $63 |
| Amgen Inc. | 2 | $37 |
| Lundbeck LLC | 1 | $31 |
| Genentech USA, Inc. | 1 | $14 |
Products named: VUMERITY, BRIUMVI, Mavenclad, KESIMPTA, TYSABRI, UBRELVY, VYEPTI, UPLIZNA.
Industry payments across VA — which companies pay providers there.
